In the preceding three months, 7 analysts have released ratings for Omnicell (NASDAQ:OMCL), presenting a wide array of perspectives from bullish to bearish. The table below offers a condensed view of ...
Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...
5 analysts have shared their evaluations of Omnicell (NASDAQ:OMCL) during the recent three months, expressing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table ...
Investor's Business Daily on MSN
Omnicell shows rising price performance with jump to 81 RS rating
Omnicell shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 81.
It scored not one, but two beats on analyst estimates for its third-quarter performance. This, despite a slight year-over-year decline in adjusted profitability. Revenue for Omnicell in its third ...
Omnicell’s updated analyst narrative keeps the modeled fair value steady at US$57.43, even as some price targets are being ...
We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this piece, we will look at where Omnicell, Inc. (NASDAQ:OMCL) ranks among the list of stocks with improving ...
Omnicell (NASDAQ:OMCL – Free Report) had its target price hoisted by Bank of America from $30.00 to $34.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results